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Immunoisolation is an important strategy to protect transplanted cells from rejection by the host immune system. Recently, 
microfabrication techniques have been used to create hydrogel membranes to encapsulate microtissue in an arrayed organiza-
tion. The method illustrates a new macroencapsulation paradigm that may allow transplantation of a large number of cells with 
microscale spatial control, while maintaining an encapsulation device that is easily maneuverable and remaining integrated 
following transplantation. This study aims to investigate the design principles that relate to the translational application of mi-
cropatterned encapsulation membranes, namely, the control over the transplantation density/quantity of arrayed microtissues 
and the fidelity of pre-formed microtissues to micropatterns. Agarose hydrogel membranes with microwell patterns were used 
as a model encapsulation system to exemplify these principles. Our results show that high-density micropatterns can be gener-
ated in hydrogel membranes, which can potentially maximize the percentage volume of cellular content and thereby the trans-
plantation efficiency of the encapsulation device. Direct seeding of microtissues demonstrates that microwell structures can ef-
ficiently position and organize pre-formed microtissues, suggesting the capability of micropatterned devices for manipulation 
of cellular transplants at multicellular or tissue levels. Detailed theoretical analysis was performed to provide insights into the 
relationship between micropatterns and the transplantation capacity of membrane-based encapsulation. Our study lays the 
ground for developing new macroencapsulation systems with microscale cellular/tissue patterns for regenerative transplanta-
tion. 
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Since the early 1950s, immunoisolation devices have been 
investigated for encapsulating living cells in semi-permea- 
ble polymeric membranes to shield them from attack from 
the immune system following therapeutic cell transplanta-
tion [1,2]. Previous studies were performed for treatment of 
various types of tissue/organ disorders, including diabetes 
[3], hypothyroid [4], kidney/liver failure [5,6], and central 
nerves system diseases [7]. Among these studies, the im-
munoisolation of allogeneic or xenogenic islets were inten-
sively examined for producing an artificial pancreas that 
does not require immunosuppression [810]. In recent years, 
with rapid developments in stem cell research and differen-
tiation protocols that can provide cell sources for various 
tissues [11–13], the need for immunoisolation devices has 
grown even greater for regenerative therapy. 
There generally exist micro- or macro-encapsulation de-
vices for immunoisolation [14,15]. In microencapsulation, 
hydrated gel networks form a thin layer on the surface of 
individual microtissues. By contrast, the macroencapsula-
tion devices are typically pre-fabricated and provide reser-
222 Jiang LY, et al.   Sci China Life Sci   February (2014) Vol.57 No.2 
voirs large enough to constrain all microtissues required for 
transplantation. Typically, macroencapsulation devices are 
polymeric membrane-based, in the form of planar sheets or 
hollow fibers [1620]. Because of their convenient maneu-
verability, one distinct advantage that macroencapsulation 
devices can offer is that the transplanted cells are totally 
retrievable or replaceable in the event of post-operative 
complications. Macroencapsulation devices therefore hold 
promise to provide off-the-shelf products for clinical use. 
Despite the feasibility and effectiveness shown in animal 
models, the translation of macroencapsulation devices into 
therapeutic products has so far been limited. This is mainly 
due to the inability of the devices to maintain efficient cell 
viability that ensures satisfactory therapeutic outcome, and 
the associated reasons are quite complex. Notably, fibrotic 
tissues resulting from the foreign-body reaction may affect 
nutrient exchange across the membrane. It is also noted that 
the macroencapsulated microtissues are randomly distrib-
uted, and the lack of spatial control may lead to clumping of 
cells and a risk of inducing tissue necrosis. In addition, the 
transplantation capacity of the device may be prohibitively 
insufficient; the volume of the device required to contain 
enough cellular content for treatment can be too large to be 
implanted in the body. 
Recently, microfabrication techniques have been applied 
to create definable microstructures in hydrogel membranes 
[2124]. In particular, hydrogel substrates patterned with 
microwells and microgrooves fabricated by micromolding 
processes enable the aggregation of cells with precise con-
trol of size, spacing and shape at the micro-level. The mi-
cromolding technique has been used to generate encapsula-
tion sheets through gelling alginates in situ to embed 
pre-assembled cell-spheroidal arrays [25,26]. In another 
study, collagen-alginate hydrogels containing arrayed islet 
cells were tested in a diabetic mouse model, with the effec-
tive control of glucose levels over a 4-week period [27]. 
Therefore, micropatterned encapsulation systems (MESs) 
present a new type of macroencapsulation device. Despite 
this, major hurdles remain to be overcome before MES can 
be used for cell/tissue transplantation. Herein, we propose to 
examine the several issues regarding the design of MES. 
First, we will investigate whether micropatterns can im-
prove microtissue density and whether the micropattern 
design can affect the transplantation capacity of the device. 
Second, given that pre-isolated or -cultured microtissues are 
often used in cell transplantation rather than single cells 
[28,29], it is important to determine whether MES can be 
used to pattern and organize microtissues directly. Third, as 
hydrogel materials are quite fragile and hard to handle, we 
will investigate whether they are suited to fabricate macro-
encapsulation devices. 
To address these questions, we used agarose-based hy-
drogel membranes to create a model macroencapsulation 
system. Fabrication of microwell patterns was investigated 
to test whether high-density arrays of cell spheroids can be 
generated through a micromolding process. NIH 3T3 fibro-
blast spheroids, self-assembled from dissociated cells, were 
used as model microtissues, and seeded directly onto aga-
rose membranes patterned with microwells. The fidelity of 
these microtissues to the topographical patterns was exam-
ined. Following this, we encapsulated cell-spheroidal arrays 
in sandwiched gel layers. A one-week preliminary experi-
ment was performed to evaluate the stability of the subcu-
taneously embedded MES. Detailed theoretical analysis was 
also performed to elucidate the relationship between micro-
patterns and the transplantation capacity of membrane- 
based encapsulation. Our study may help to lay foundations 
for designing a new generation of immunoisolation devices 
for cell-based therapy. 
1  Materials and methods 
1.1  Materials and cell culture 
Water was distilled and deionized at 18 M resistance (Ge-
lante Pure Water, China). Agarose (type IX-A, ultra-low 
gelling temperature (ULGT)) was purchased from Sig-
ma-Aldrich (USA). NIH 3T3 fibroblasts were obtained from 
the Cell Culture Center of the Institute of Basic Medical 
Sciences (Beijing, China). Human hepatocellular carcinoma 
HepG2 cells were a kind gift from Dr. Hongkui Deng (Col-
lege of Life Sciences, Peking University, Beijing, China). 
All cell culture reagents were purchased from Invitrogen 
(USA), unless otherwise specified.  
Cells were cultured under a humidified atmosphere with 
5% CO2 at 37°C. Cell media were replaced every 2–3 days. 
HepG2 and NIH 3T3 cells were both maintained in DMEM 
supplemented with 10% fetal bovine serum and 1% penicil-
lin/streptomycin. 
1.2  Generation of microwell-patterned agarose mem-
branes  
Silica (Si) wafers were fabricated with microwell patterns of 
pre-defined feature sizes via standard photolithographic 
techniques (First MEMS Corp., China). The height of the 
micropatterns was 80 µm. From these master patterns, com-
plementary polydimethylsiloxane (PDMS) replicas were 
prepared by curing the PDMS prepolymers (mixed at 10:1 
ratio with the crosslinking catalyst Sylgard 184, Dow Corn-
ing Corp., USA) over the Si master at 80°C for 2 h; the re-
sulting PDMS molds were peeled off and cut into stamps 
with 5 mm×5 mm patterned surfaces. The trimmed PDMS 
molds were further cleaned in a 70% ethanol solution, ex-
posed under UV light for 30 min for sterilization and stored 
for future use. 
To generate micropatterned hydrogel membranes, we 
dissolved ULGT agarose powder in phosphate-buffered 
saline (PBS) at 60°C to a concentration of 30 mg mL1. The 
resulting pre-gel stock solutions were sonicated for 30 min 
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to remove bubbles. 180 μL solutions were then pipetted into 
48-well plates or 8-well Lab-Tek chamber slides (Nunc, 
Thermo Fishers, USA) and micromolded by placing PDMS 
stamps with negative microwell patterns on top of the aga-
rose liquid. The gels were cured overnight at 4°C and the 
resulting microwell-patterned membranes were used for cell 
culture.  
1.3  Imaging analysis of microwell-patterned agarose 
membranes 
The agarose membranes were characterized by stylus pro-
filometry (Dektak 150 Veeco Metrology, USA) to analyze 
of the depth of the patterns on the surface. Specifically, a 
micropatterned membrane on top of a glass slide was placed 
on the sample stage and the stylus was moved along a se-
lected straight line across the microwell patterns. The step 
height between the lower bottom and the upper ridge of the 
well was thus obtained. 
Phase-contrast microscopy was conducted to image the 
agarose membranes with and without cells from the top 
using an IX71 fluorescence microscope (Olympus, Japan). 
To obtain the side-view of the microwell pattern, we care-
fully sliced hydrogel samples prepared in Lab-Tek chamber 
slides across the microwells into 2-mm-wide strips. The 
hydrogel strip was then flipped onto its side on a coverslip 
for image analysis. 
1.4  Generation of encapsulated microtissue arrays 
from dissociated cells or pre-formed multi-cellular 
spheroids 
To seed HepG2 hepatocytes or NIH 3T3 fibroblasts on mi-
crowell-patterned membranes, we suspendeded dissociated 
cells in media at 2×105 cell mL1, and the suspensions were 
pipetted at 0.4 mL/well onto the microwell-patterned mem-
branes in 48-well plates. Cells were allowed to sediment to 
the bottom of microwells. After 24 h, the supernatant was 
then carefully aspirated to remove unattached floating cells 
and fresh media were added. To generate the sandwiched 
encapsulation model, we pipetted 20 μL pre-gel agarose 
solutions onto microwells containing microtissue arrays and 
allowed to gel at 4°C for 30 min. The hydrogel membrane 
containing the encapsulated microtissues was maintained 
for up to 20 d, with medium exchange every other day. The 
assembled cellular spheroids in the microwells were imaged 
via phase-contrast microscopy. 
To investigate the seeding of pre-formed spheroids, we 
plated the fibroblast spheroids at 8.0×104 cells/well on 
24-well ultra-low attachment plates (Corning, USA) and 
rotated at 160 r min1 for 15 min on an orbital shaker every 
30 min for four repeats and then cultured without motion in 
an incubator for several hours. Once the multi-cellular 
spheroids were formed, they were collected by centrifuga-
tion at RCF 160×g for 5 min.  
To quantitatively analyze spheroid size and numbers, we 
resuspended the cellular spheroids in 150 μL culture medi-
um and plated on 96-well plates. Four fields of view (upper 
left, upper right, lower left and lower right) that cover the 
whole bottom area of the well under 4× magnification were 
selected and phase contrast images were recorded. The di-
ameters of the spheroids were determined through meas-
urement of the pixel numbers of lines drawn crossing the 
spheroids, followed by conversion to actual lengths using 
ImageJ analysis software (NIH, USA). Spheroid numbers 
were also counted in each field of view. 
To analyze the distribution of spheroids settled within 
microwells, we seeded spheroids collected from one, two 
and three wells of ultra-low attachment plates onto different 
microwell patterns. After 24 h, the microwells were divided 
into four cornered regions and phase contrast images were 
recorded at 4× (objective lens) magnification. The four im-
ages were pieced together to obtain the full view of the pat-
terned area (5 mm×5 mm).  
1.5  Cell viability and functional secretion maintained 
in agarose-based MES 
The spheroid arrays were stained with Hoechst 33342 and 
propidium iodide (PI) (Sigma-Aldrich, USA) at prescribed 
time points to detect cell viability/death according to the 
manufacturer’s instructions. Necrosis was determined on 
the basis of positive PI staining in red color, indicative of 
loss of membrane integrity. 
To evaluate the function of encapsulated microtissues in 
sandwiched membranes, we examined the secretion of al-
bumin and vascular endothelial growth factor (VEGF) from 
HepG2 hepatocytes and NIH 3T3 fibroblasts, respectively. 
Specifically, after HepG2 cells were seeded and encapsu-
lated in the micropatterned membrane, the cell culture me-
dium was collected at prescribed time points for each sam-
ple and frozen at 20°C for analysis. Then, 400 μL of fresh 
medium was added and the protein concentration in the 
culture medium from the collected samples were measured 
using commercial albumin (Bethyl Laboratories, USA) and 
VEGF (Quantikine®, R&D Systems, USA) ELISA kits, 
following the manufacturer’s instructions. 
1.6  Subcutaneous implantation of agarose-based MES 
All procedures were performed in accordance with the reg-
ulations approved by the Institutional Animal Care and Use 
Committee (IACUC) of the Peking University. Six Spra-
gue-Dawley (SD) rats weighing 290–320 g were housed in 
separate cages and cared for in compliance with protocols 
approved by the Animal Ethnics Committee at Peking Uni-
versity. Rats were anaesthetized with an intraperitoneal in-
jection of chloral hydrate (400 mg kg1). Four 1-cm inci-
sions were prepared (two in the left back; two in the right 
back), and four subcutaneous pouches (about 8×8 mm) were 
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created lateral to the incisions, at 2 cm intervals, by gentle 
blunt dissection with scissors. Sandwiched agarose mem-
branes containing NIH 3T3 fibroblast spheroids, that had 
been prepared and cultured for 4 d in the Lab-Tek plate in 
vitro, were placed into the pocket. Four disks, one over each 
hip and shoulder, were placed in each rat. Incisions were 
closed with sutures and the animals were observed until 
recovery and housed for prescribed time. Animals were 
sacrificed 7 d post-implantation by CO2 asphyxiation.  
1.7  Histological analysis  
Implants and surrounding tissue were harvested from sacri-
ficed rats, fixed in 4% paraformaldehyde, and dehydrated 
sequentially in a series of graded ethanol with concentration 
at 70%–100% before paraffin embedding. The embedded 
hydrogel-tissue samples were subsequently microtomed into 
6-μm-thick sections and stained with hematoxylin and eosin 
(H&E) via a standard protocol. The histological images 
were obtained using a BX51 microscope (Olympus) under 
bright-field mode. 
1.8  Quantitative analysis 
Statistical comparisons were performed by one-way analy-
sis of variance (ANOVA) followed by the Newman-Keuls 
test to compare data pairs using SigmaStat 3.5 software 
(Systat Software Inc., USA), and the difference was con- 
sidered statistically significant when P<0.05. All quantita-
tive results were presented as means±standard deviation 
(SD). 
2  Results 
2.1  Generation of high-density microtissue arrays on 
agarose membranes 
The agarose hydrogel membranes patterned with microwell 
structures were fabricated through a micromolding process 
using a PDMS stamp. To build the encapsulation model, we 
dispensed pre-gel solutions to cover the microwells once the 
cellular spheroid arrays were formed (Figure 1A). We chose 
hexagonal tiling, the densest way to arrange circles in two 
dimensions, to create microwells with a diameter of 100 or 
200 μm. To vary the density of microwells, we defined the 
peripheral distance between two neighboring microwells (d), 
as shown in Figure 1B, at either 1/2 or 1/4 of the microwell 
radius (r). 
All four types of microwell patterns were successfully 
created and the resulting hydrogel membranes could be re-
moved from the container that initially held the gel solution 
(Figure 2A). From the side-view, the whole thickness of the 
membranes was measured at 204.25±46.54 μm (n=8) (Fig-
ure 2B). The characterization by contact profilometry tech- 
 
 
Figure 1  A, Schematic fabrication of micropatterned membranes and sandwiched encapsulation system. B, Schematic illustration of the dense hexagonal 
arrangement of the circular microwells.  
 
Figure 2  A, Agarose membranes with microwell patterns. B, The side-view of a micropatterned agarose membrane, with the arrow indicating the surface 
of the microwells. C, Profilometric characterization of the microwell depths. 
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niques indicated that the depth of microwells was 61.3±  
4.1 μm (n=3) (Figure 2C).  
When dissociated single cells, either HepG2 hepatocytes 
or NIH 3T3 fibroblasts, were seeded into microwells, they 
were found to settle at the bottom of the microwells. The 
process occurred within a few minutes and the percentage 
of microwells filled with cells generally reached 80%–90% 
at 24 h (Figure 3 and Table 1). The average diameter of 
spheroids increased with the size of microwells. From the 
statistical results of both 100-μm and 200-μm microwells, it 
is noted that the HepG2 spheroids tend to be smaller in mi-
crowells of higher density (Table 1). 
2.2  Direct seeding of pre-assembled cellular spheroids 
onto agarose microwells 
Both HepG2 hepatocytes and NIH 3T3 fibroblasts formed 
3-D multicellular aggregates on ultra-low attachment plates. 
However, the aggregation of HepG2 hepatocytes resulted in 
irregular shapes (Figure S1 in Supporting Information), 
while NIH 3T3 fibroblast aggregates were obtainable with 
Table 1 Different types of microwells and formation of multi-cellular 















100-A 100 25 89±7.1 62.8±8.8 
100-B 100 12.5 78.2±7.8 49.5±8.7 
200-A 200 50 90.9±5.0 108.6±13.2 
200-B 200 25 88.7±2.6 87.2±8.2 
 
spheroidal shape. The typical diameter of these fibroblasts 
spheroids was in the range of 30–100 μm, with the peak 
value at 40–50 μm (Figure 4). The spheroids were then used 
as microtissues and directly plated into different types of 
microwells. 
Specially, to seed fibroblast microtissues, we varied the 
spheroid/microwell ratio (S/M ratio) from 0.35 to 1.15 and 
1 to 4 for 100-μm and 200-μm microwells, respectively. 
Like dissociated cells, the fibroblast spheroids were cap-
tured by microwells within a few minutes following seeding 
(Figure 5A and B). While most of the 100-μm microwells 
contained no more than one microtissue, many 200-μm mi-
crowells captured two or more spheroids (Figure 5C and D). 
The percentage of microwells containing microtissues in-
creased with the number of initially plated spheroids until 
the majority of microwells were filled (Figure 6A). When 
comparing microwells of different sizes, the S/M ratio 
needed to reach 1.1 and 2.1 for 100-μm and 200-μm mi-
crowells, respectively, to have over 80% containing sphe-
roids. The distance between microwells did not have signif-
icant impact on the microwell filling ratio. In addition, a 
very high level of fidelity of the spheroids was observed as 
can be seen in the trend in Figure 6B, which indicat es that 
about 70%–80% of the initially seeded spheroids were gen-
erally located in microwells. 
2.3  Viability and function of cells encapsulated in 
sandwiched membranes  
After adding the overlayer of gel solution onto the top of the 
agarose membrane, cell spheroids formed from single cells   
 
 
Figure 3  Dissociated HepG2 cells self-assembled into spheroids in different types of microwells. A, B, C and D correspond to the 100-A, 100-B, 200-A 
and 200-B membranes as listed in Table 1, respectively.  
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Figure 4  Aggregation of fibroblast cells on ultra-low attachment microplates and the size distribution of the resulting multi-cellular spheroids.  
 
Figure 5  Preformed NIH 3T3 fibroblast spheroids spontaneously located in the microwells at 24 h (S/M ratio: 1~1.2). A, B, C and D correspond to the 
100-A, 100-B, 200-A and 200-B membranes, respectively. The white arrows in B indicate floating spheroids in the supernatant. 
in microwells were maintained in the sandwiched mem-
branes for up to 3 weeks. As shown in Figure 7, with pro-
longed cell culture, the Hoechst 33342/PI assay showed few 
necrotic cells. Unlike the cells in the early period of culture, 
the cells appeared to fuse together with prolonged culture 
time, as cell membranes or individual cells became indis-
tinguishable. 
The paracrine secretion of albumin and VEGF from 
HepG2 hepatocyte and NIH 3T3 fibroblast spheroids, re-
spectively, were monitored over a 2-week period (Figure 8). 
During this time, the paracrine secretion of both types of 
spheroids increased in the first week and then maintained a 
steady level. Although the encapsulated cells showed a 
lower level of secretion at some time points, the production 
rate/quantity of albumin and VEGF by spheroids with or 
without the encapsulating layer was generally comparable.  
2.4  Subcutaneous encapsulation 
To investigate the suitability of hydrogel membranes for 
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Figure 6  Statistical profiling of fibroblast spheroids captured by different micropatterned membranes. A, The percentage of microwells containing fibro-
blast spheroids. B, The percentage of spheroids captured by microwells versus the total seeded spheroids (n=3). 
 
Figure 7  A, Phase contrast image of the spheroids encapsulated in agarose-based MES at 22 d. B, Nuclei of all viable cells stained with the Hoechst 33342 
dye are shown in blue. C, Necrotic cells stained with propidium iodide are shown in red. 
 
Figure 8  Albumin secretion by HepG2 hepatocyte spheroids (n=5) (A) and VEGF secretion by NIH 3T3 fibroblast spheroids (n=4) (B) in the microwells 
with or without the encapsulating layer. 
transplantation applications, we embedded the encapsulat-
ing membranes with a total thickness about 0.5 mm in the 
subcutaneous tissue of a rat model (Figure 9A). When the 
tissue was opened up one week later, the macroencapsula-
tion membrane was found to have remained at the implanta-
tion site; however, it was surrounded by connective tissue 
(Figure 9B). By histology analysis, microwell pattern con-
taining cells were observed. It is hard to judge whether the 
cells remaining in the micropatterns were implanted cells or 
infiltrated ones from the host tissue (Figure 9C). Some de-
gree of foreign-body response was observed at the periphery 
of the implanted encapsulation system. (Figure 9D).  
3  Discussion 
Current macroencapsulation devices are mainly made of 
planar or tubular membranes with the capacity to isolate 
cells from the attack of the host immune system. For exam-
ple, TheraCyte™ devices encapsulate cells/tissues in sealed 
polytetrafluoroethylene (PTFE)-based membranes [30,31]; 
islets were also encapsulated in stainless steel mesh tubes 
with an interior PTFE rod [32]. In these devices, the spatial 
distribution of microtissues is random, uncontrollable and 
therefore unable to maintain the microtissues separated 
when closely packed together. Macroencapsulation devices 
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Figure 9  A, Sandwiched agarose membranes containing NIH 3T3 fibroblast spheroids. B, Implanted membranes (in the area circled by white broken lines) 
7 d post-implantation. C, H&E stained section containing micropatterned regions. D, H&E stained sections showing the interface between the device and the 
host tissue. 
featured with microstructural patterns ushered in the con-
cept of generating cellular organization at the microscale 
level. The design may be able to minimize the transplanta-
tion volume, increase the encapsulation efficiency and im-
prove the cell viability. Understanding the packing theory of 
microtissues in MES is therefore a prerequisite for estab-
lishing key design principles for this new type of device.  
The device with patterned microwells is essentially a 2-D 
system. If the microwells were arranged through hexagonal 
close-packing, the percentage area of the microwells   
(Amicrowell%) on the membrane varies with the radius (r) of 
and the peripheral distance (d) between microwells. Figure 
10A draws the trend of Amicrowell% with a normalized pa-
rameter, d/r. When d is 1/4 or 1/2 of r, as in the membranes 
created in this study, Amicrowell% is 71.7% and 58%, respec-
tively. By contrast, we can also monitor the percentage 
volume of the microwells (Vmicrowell%) when the spatial fea-
ture of the microwell and thickness (t) of the device is var-
ied (Figure 10B). In a typical MES, where d and r are 25 
μm and 100 μm, respectively, the total volume of the device 
could be no more than two- or three-fold the volume of the 
spheroidal microtissues. Figure 10C shows a chart from 
which the number of microwells can be obtained given the 
device geometry. It can be seen that within a 10 cm × 10 cm 
device, there could be 9.1×105 or 2.3×105 microwells with a 
diameter of 100 μm or 200 μm (d/r = 1/2), respectively. The 
number matches the total islet cell number required for 
clinical transplantation [15,3335]. The detailed calculation 
formulas for theoretical analysis are shown in Figure S2 in 
Supporting Information.  
The above analysis of microwell packing is theoretical. 
In reality, the generation of substrates with a high-density of 
microwell arrays may be limited by the mechanical strength 
of the materials as well as the micromolding process itself. 
In our study, we found that the microwells could maintain 
their pre-designed shape even when the distance between 
microwells was reduced to 12.5 μm. The pattern was also 
stable after the agarose membrane was immersed in culture 
medium or transplanted in vivo. Further increasing the mi-
crowell density could result in defects given the fragility of 
hydrogel materials. 
Stem cell research has grown into an active field in the 
last two decades and holds great promise to provide revolu-
tionary regenerative treatment for tissue repair [36,37]. 
Protocols have become available to allow scalable produc-
tion of stem cells. Moreover, stem cells can be guided in 
definable ways to differentiate into diverse types of special-
ized cells. To make these specialized cells functional in vivo, 
new strategies have emerged in recent years to culture 3-D 
multicellular constructs to promote tissue morphogenesis 
[38,39]. Given the likelihood that spheroidal microtissues 
may be harvested from stem cell culture for transplantation, 
it is important to understand whether the microtissue entities 
can be manipulated and assembled on substrates or scaf-
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Figure 10  Graphical results showing (A) the percentage area (Amicrowell%), (B) the percentage volume (Vmicrowell%) and (C) the number of microwells via 
hexagonal close-packing in membranes of defined geometrical parameters. R, the radius of microwells; d, the peripheral distance between microwells; t, 
thickness of the device; w, the length of the square device.  
folds. When the dissociated cells were seeded into mi-
crowells, it was shown that the number of cells trapped in 
microwells follow a Poisson distribution [40,41]. Mi-
crowells could be used to capture single cells and thus study 
stem cell fate [42]. However, direct seeding of microtissues 
has not been previously investigated. Herein, we provide 
evidence that spheroidal microtissues, like the dissociated 
cells, can be entrapped in microwell structures on the sur-
face of hydrogel membranes. The spheroid distribution pat-
terns vary with the microwell size. We show in our experi-
ments that the distribution of spheroids was more homoge-
neous on 100-μm microwells than that on 200-μm mi-
crowells. The reason could be that the size of spheroids col-
lected from low attachment microplates matched more 
closely with 100-μm microwells. In contrast, larger mi-
crowells may have difficulty in trapping single spheroids in 
one well and multiple spheroids could aggregate and fill the 
microwell. 
In previous studies, microtissues assembled in mi-
crowells with a concave bottom were encapsulated in algi-
nate-based hydrogels and removed from the original mold 
[2527]. The resulting encapsulation membranes had one 
side with arrayed protrusions containing microtissues. Alt-
hough the membranes enabled dense packing of microtis-
sues, there are problems associated with this method for 
making devices for clinical application. First, it is hard to 
achieve complete or controllable encapsulation of microtis-
sues contained in the microwell mold. Separating the hy-
drogel membranes from the mold may cause damage to the 
encapsulation microstructures. In addition, the protrusions 
of the membrane may not represent the optimal surface in 
vivo. In this study, we propose to use sandwiched mem-
branes as a prototype macroencapsulation system. Although 
the bonding between the bottom and top gel layers may be 
weak, the fabrication of the device is simple, and allows for 
the control of membrane thickness and surface features. Our 
results on the viability and functions of microtissues encap-
sulated in sandwiched membranes show that the agarose 
material may afford some level of immunoisolation activity, 
by allowing sustainable delivery of paracrine factors and the 
diffusion of oxygen, nutrients and metabolic waste products. 
However, the in vivo study needs further investigation, as 
the number of cells maintained in the micropattern may well 
below the implanted cell number. This limitation could be 
related to the weak mechanical properties of the hydrogel or 
the imperfect sealing of the two gel layers. In addition, the 
agarose membrane may not be capable of preventing the 
permeation of antibodies and complement proteins [43]. 
Future efforts need to determine a chemistry that bond the 
two gel layers together and optimize the mechanical and 
transport properties of immunoisolation materials. Incorpo-
ration of extracellular components in encapsulation mem-
branes may also be necessary to promote cell viability and 
function within the device [26,44].  
In conclusion, using an agarose hydrogel model, we in-
vestigated key principles relating to designing MES to 
transplant microtissues with microscale spatial control. Our 
study shows that high-density microtissue arrays can be 
generated in micropatterned membranes. The cell density 
within the device can reach a high level that minimizes the 
size of the transplantation device. The microwell structures 
are also effective for directly positioning and organizing 
microtissue entities, indicating the suitability of the mem-
brane-based devices for manipulating cells at the multicel-
lular level. MES could therefore offer a promising approach 
for transplanting large quantities of cells/tissues via 
high-density arrayed patterns. Further development of the 
macroencapsulation system should be investigated to im-
prove the mechanical stability and biochemical properties of 
the membrane materials for supporting long-lasting viability 
of transplanted cells. 
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